STOCKHOLM, March 12, 2021 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO: SOBI) today announces that the first patient has been dosed with avatrombopag, a thrombopoietin receptor ...
Sanofi (SNYNF) announced an update on their ongoing clinical study. Study Overview Sanofi has completed an observational study titled “Cognitive Status, Fatigue, and Inflammation in Patients With ...
ATLANTA, Dec. 9, 2019 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced positive results from a Phase II study (TP0001; NCT02718716) of its novel, first-in-class subcutaneous ...
New prospective research builds on a previous study that showed guidelines aren’t the main driver of treatment selection in pediatric patients with ITP. Of 12 potential reasons for prescribing ...
"Care of the elderly has become its own science and is very different in virtually everything than is the care of a typical middle-aged adult. This is important for ITP." — James Bussel, MD Reflecting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback